Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Linvoseltamab in Newly Diagnosed Multiple Myeloma
NCT06376526Phase 2Recruiting
- Start
- Aug 2024
- Primary completion
- Aug 2027
- Countries
- 1
01
Overview
A Phase 2 trial of linvoseltamab in multiple myeloma (MM). Started Aug 2024; status: recruiting.
02
Drugs
linvoseltamab
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT06376526.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06376526.